000			01218cam a2200325 a 4500
008			830125s1983 dcua b 000 0 eng
020			_a0844735175 (pbk.)
040			_aDLC _cDLC
050	0	0	_aKF3885 _b.G7 1983
082	0	0	_a344.0416 _bGRA
100	1		_aGrabowski, Henry G.
245	1	4	_aThe regulation of pharmaceuticals : _bbalancing the benefits and risks /
260			_aWashington : _bAmerican Enterprise Institute for Public Policy Research, _cc1983.
300			_a74 p. :
440		0	_aAEI studies ;
504			_aInludes bibliographical references.
520			_aThe book reviews the empirical evidence concerning the FDA's effect on the rate of innovation, the delays in introducing new drugs in the United States compared with Great Britain and other countries, the profitability of pharmaceutical research, and the reduction of risk to patients resulting from regulation.
590			_aoif 04/08/16
591			_aLoan
650		0	_aDrugs
650		0	_aPharmacy
650		2	_aDrug industry
650		2	_aDrugs
650		2	_aLegislation, Drug
650		2	_aResearch
651			_aUnited States of America
700	1		_aVernon, John M.
942			_2ddc _cBOOK
949			_a344.0416 GRA
999			_c4209 _d4209